Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis
Moisés Selman, Annie Pardo
Cellular Signalling (2019) Vol. 66, pp. 109482-109482
Closed Access | Times Cited: 179

Showing 26-50 of 179 citing articles:

Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
Anna Valeria Samarelli, Roberto Tonelli, Alessandro Marchioni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8952-8952
Open Access | Times Cited: 47
A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality
Anurag Verma, Jessica Minnier, Emily S. Wan, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 10, pp. 1220-1229
Open Access | Times Cited: 32
Mechanotransduction Regulates the Interplays Between Alveolar Epithelial and Vascular Endothelial Cells in Lung
Chuyang Lin, Xiaolan Zheng, Sha Lin, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 29
Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis
Shan Wang, Wei Rao, Ashley Hoffman, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 693
Open Access | Times Cited: 22
Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis
Jiurong Liang, Guanling Huang, Xue Liu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 22
Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases
Takuma Isshiki, Safaa Naiel, Megan Vierhout, et al.
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108578-108578
Closed Access | Times Cited: 18
p53 and Myofibroblast Apoptosis in Organ Fibrosis
Kealan McElhinney, Mustapha Irnaten, Colm O’Brien
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6737-6737
Open Access | Times Cited: 17
YTHDC1 delays cellular senescence and pulmonary fibrosis by activating ATR in an m6A-independent manner
Canfeng Zhang, Liping Chen, Chen Xie, et al.
The EMBO Journal (2023) Vol. 43, Iss. 1, pp. 61-86
Open Access | Times Cited: 17
Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis
Ahmed Raslan, Tho X. Pham, Jisu Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Role of mitochondria in inflammatory lung diseases
Venkata Ramireddy Narala, Sahithi Reddy Narala, Parasuraman Aiya Subramani, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine
Moisés Selman, Annie Pardo
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 9, pp. 1074-1081
Closed Access | Times Cited: 6
Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic
Dailin Yuan, Yufei Bao, Ahmed El-Hashash
American Journal of Stem Cells (2024) Vol. 13, Iss. 2, pp. 37-58
Open Access | Times Cited: 6
A glitch in the matrix: organ-specific matrisomes in metastatic niches
Sarah K. Deasy, Neta Erez
Trends in Cell Biology (2021) Vol. 32, Iss. 2, pp. 110-123
Closed Access | Times Cited: 33
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
Gustavo Ramírez-Martínez, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 8, pp. 352-368
Open Access | Times Cited: 24
3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening
Ana Ivonne Vazquez‐Armendariz, M.M. Barroso, Elie El Agha, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1526-1526
Open Access | Times Cited: 23
Fibrosis pulmonar idiopática
Francisco León, Claudia Valenzuela, María Molina‐Molina
Medicina Clínica (2022) Vol. 159, Iss. 4, pp. 189-194
Closed Access | Times Cited: 23
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 23
Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
Takuma Isshiki, Megan Vierhout, Safaa Naiel, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115501-115501
Closed Access | Times Cited: 15
Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030
Qi Zeng, Depeng Jiang
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 15
Menstrual blood-derived stem cells exosomal miR-let-7 to ameliorate pulmonary fibrosis through inhibiting ferroptosis by Sp3/HDAC2/Nrf2 signaling pathway
Lifang Sun, Xinxin He, Jiao Kong, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111316-111316
Closed Access | Times Cited: 15
Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis
Amit Kumar, Evan A. Elko, S. Bruno, et al.
Thorax (2021) Vol. 77, Iss. 7, pp. 669-678
Open Access | Times Cited: 32
Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis
Pitchumani Sivakumar, Ron Ammar, John Ryan Thompson, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury
Sisi Wang, Xue Li, Qingwen Ma, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 728-728
Open Access | Times Cited: 22
Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals
Yinci Zhang, Jiaojiao Liang, Niandie Cao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 22
The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases
Beatriz Tlatelpa-Romero, Verna Cázares‐Ordoñez, Luis F. Oyarzábal, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 326-326
Open Access | Times Cited: 20

Scroll to top